| abstract |
(57) [Summary]nMethods are provided for treating erectile dysfunction in a male male individual. The method includes topical administration of the phosphodiesterase inhibitor or a pharmaceutically acceptable salt, ester, amide or derivative thereof in the context of an effective dosage regime. A preferred mode of administration is the transurethra. Pharmaceutical formulations and kits are also provided. |